Showing results (141-150 of 174) with videos related to
Sort By:
Pageof 18
Cardiovascular Revascularization Medicine : Including Molecular Interventions|October 7, 2014
Comparison of sirolimus- and paclitaxel-eluting stents in patients with moderate renal insufficiency: results from the J-DESsERT trialMasaya Otsuka, Hiroyoshi Yokoi, Yutaka Matsuyama, et al.Cardiovascular Drugs and Therapy|June 1, 2013
Beneficial effects of intracoronary nicorandil on microvascular dysfunction after primary percutaneous coronary intervention: demonstration of its superiority to nitroglycerin in a cross-over studyNoritoshi Ito, Shinsuke Nanto, Yasuji Doi, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|December 27, 2007
Effect of early use of low-dose pravastatin on major adverse cardiac events in patients with acute myocardial infarction: the OACIS-LIPID StudyHiroshi Sato, Kunihiro Kinjo, Hiroshi Ito, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|April 11, 2014
Introduction of point-of-care testing in Japanese outpatient clinics is associated with improvement in time in therapeutic range in anticoagulant-treated patientsYuji Okuyama, Miyuki Matsuo, Hiroshi Matsuo, et al.The American Journal of Cardiology|August 22, 2016
Effect of Optimal Medical Therapy Before Procedures on Outcomes in Coronary Patients Treated With Drug-Eluting StentsRaisuke Iijima, Masato Nakamura, Yutaka Matsuyama, et al.Expert Opinion on Pharmacotherapy|February 22, 2018
A noninferiority confirmatory trial of prasugrel versus clopidogrel in Japanese patients with non-cardioembolic stroke: rationale and study design for a randomized controlled trial - PRASTRO-I trialTakehiko Nagao, Kazunori Toyoda, Kazuo Kitagawa, et al.Journal of Cardiology|September 20, 2011
Oral treatment with nicorandil at discharge is associated with reduced mortality after acute myocardial infarctionYasuhiko Sakata, Daisaku Nakatani, Masahiko Shimizu, et al.The Lancet. Neurology|February 21, 2019
Comparison of prasugrel and clopidogrel in patients with non-cardioembolic ischaemic stroke: a phase 3, randomised, non-inferiority trial (PRASTRO-I)Akira Ogawa, Kazunori Toyoda, Kazuo Kitagawa, et al.BMJ Open|September 19, 2014
Reduced risk of recurrent myocardial infarction in homozygous carriers of the chromosome 9p21 rs1333049 C risk allele in the contemporary percutaneous coronary intervention era: a prospective observational studyMasahiko Hara, Yasuhiko Sakata, Daisaku Nakatani, et al.Journal of Cardiology Cases|December 12, 2018
Plaque regression associated with everolimus administration after heart transplantationDaisaku Nakatani, Jun-Ichi Kotani, Koichi Tachibana, et al.Pageof 18